AVEO PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2014 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2014 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.49M, a 6.07% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $5.53M, a 25.2% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.14M, a 118% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.36M, a 0.13% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $2.36M, a 7.38% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $5.53M $1.49M +$85K +6.07% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $5.44M $1.41M +$237K +20.3% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $5.21M $1.27M +$63K +5.23% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $5.14M $1.37M +$728K +114% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 $4.41M $1.4M +$807K +136% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $3.61M $1.17M +$591K +102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.02M $1.2M +$661K +122% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2.36M $640K +$136K +27% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $2.22M $594K -$92K -13.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.31M $578K -$6K -1.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.32M $543K -$41K -7.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.36M $504K -$154K -23.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $2.51M $686K +$2K +0.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.51M $584K -$37K -5.96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.55M $584K +$1K +0.17% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $2.55M $658K +$343K +109% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 $2.2M $684K +$393K +135% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.81M $621K +$345K +125% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.47M $583K +$376K +182% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.09M $315K +$144K +84.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $945K $291K +$86K +42% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $859K $276K +$43K +18.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $816K $207K -$183K -46.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $999K $171K +$221K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $778K $205K -$139K -40.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $917K $233K -$178K -43.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.1M $390K -$37K -8.67% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $1.13M -$50K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 $344K -$831K -70.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $411K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $427K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 $1.18M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.